COMMUNIQUÉS West-GlobeNewswire

Ambu A/S: Interim report Q3 2017/18
23/08/2018
Ambu reports organic growth of 17% in Q3 and raises its outlook for this year's EBIT margin by 1 percentage point. Moreover, the target for sales of endoscopes is increased to 550,000 units. "Our business is moving [...]
SOLAR-1 trial of Novartis investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) meets primary endpoint in HR+/HER2- advanced breast cancer with PIK3CA mutation
23/08/2018
SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients with PIK3CA mutations who progressed on or following treatment with an aromatase inhibitor with or without a [...]
INNATE PHARMA ANNOUNCES A CHANGE TO ITS 2018 FINANCIAL CALENDAR
23/08/2018
Innate Pharma announces a Change to its 2018 financial calendar Marseille, France, August 23, 2018 Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announced a change to its 2018 financial [...]
INNATE PHARMA ANNONCE UNE MODIFICATION DE SON CALENDRIER FINANCIER 2018
23/08/2018
Innate Pharma annonce une Modification de son calendrier financièr 2018 Marseille le 23 août 2018 Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 - IPH) annonce une modification de son calendrier de [...]
IBA SA : IBA Reports Half Year Results for 2018
23/08/2018
IBA Reports Half Year Results for 2018 Group revenue of EUR 115 million, with revenues weighted to H2 Five Proteus ® ONE solutions sold in the period, of which three contracts are awaiting financing and one is a term [...]
IBA SA : IBA annonce ses résultats semestriels pour 2018
23/08/2018
IBA annonce ses résultats semestriels pour 2018 Des revenus d'EUR 115 millions pour le Groupe, avec une pondération des revenus sur S2 Cinq solutions Proteus ® ONE vendues au cours du semestre dont trois contrats en [...]
Probiodrug AG to Publish First Half 2018 Results on August 30, 2018
23/08/2018
Probiodrug AG to Publish First Half 2018 Results on August 30, 2018 HALLE (SAALE), Germany, 23 August 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel [...]
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results
23/08/2018
Provides participation details for Thursday, August 23 call NEW HAVEN, Conn., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), wishes to remind investors and shareholders [...]
Merus annonce la création d'un comité consultatif scientifique
23/08/2018
- Des oncologues et des professionnels du développement pharmaceutique clés vont apporter leur soutien aux progrès du pipeline d'anticorps bispécifiques de Merus - UTRECHT, Pays-Bas, 23 août 2018 (GLOBE NEWSWIRE) -- [...]
Vigil Health Solutions Completes 2018 AGM
23/08/2018
VICTORIA, British Columbia, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”), is pleased to announce that, at its 2018 AGM shareholders elected Troy Griffiths, Greg Peet, Ian Power and Lindsay [...]
ContraFect to Present at ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
22/08/2018
YONKERS, New York, Aug. 22, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
UPDATE: Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
22/08/2018
THE WOODLANDS, Texas, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference: [...]
Aduro Biotech Granted Composition of Matter Patent for Novel Human APRIL Binding Antibodies
22/08/2018
BERKELEY, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that the United States Patent and Trademark Office has issued a new composition of matter patent related to altered [...]
Tonix Pharmaceuticals Announces Director Stepping Down
22/08/2018
NEW YORK, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that Samuel Saks, M.D. has stepped down from the Company’s board of directors, effective August 21, [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
22/08/2018
BOSTON, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference: 2018 Wells Fargo [...]
OSE Immunotherapeutics Publishes New Efficacy Data on FR104, CD28-Antagonist Immunotherapy
22/08/2018
FR104 shown to be efficacious in a preclinical bone marrow transplant model Research published in the Journal of Clinical Investigation conducted with multiple international expert partners NANTES, France, Aug. 22, 2018 [...]
La 19e conférence mondiale de l'IASLC sur le cancer du poumon aura lieu à Toronto au Canada
22/08/2018
DENVER, 22 août 2018 (GLOBE NEWSWIRE) -- L'évènement : l’International Association for the Study of Lung Cancer (IASLC) organise la 19e conférence mondiale sur le cancer du poumon (WCLC) du 23 au 26 septembre 2018, à [...]
Compass Peak Imaging Goes Live on Full Suite of eRAD Solutions
22/08/2018
Ability to scale proves decisive for outpatient imaging provider GREENVILLE, S.C., Aug. 22, 2018 (GLOBE NEWSWIRE) -- eRAD announced today that Compass Peak Imaging has successfully deployed a full suite of the company’s [...]
ALK submits registration application for tree SLIT-tablet in Europe
22/08/2018
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that the European regulatory filing for its investigational tree pollen sublingual allergy immunotherapy (SLIT) tablet has been accepted for review by the [...]

Pages